Neonatal group B streptococcal disease: incidence, presentation, and mortality

J Matern Fetal Neonatal Med. 2008 Jan;21(1):53-7. doi: 10.1080/14767050701787474.

Abstract

Objectives: To ascertain the incidence, and compare the clinical characteristics, laboratory parameters, and immediate mortality of neonates with early-onset (symptomatic and asymptomatic) and late-onset group B streptococcal (GBS) disease.

Methods: A chart review of 81 neonates with GBS disease (either blood and/or cerebrospinal fluid culture-proven) born between 1995 and 2002 admitted to two tertiary care perinatal centers in Toronto was conducted. Clinical characteristics were compared for (1) asymptomatic early-onset, symptomatic early-onset, and late-onset GBS disease and (2) survivors and non-survivors.

Results: The incidence of GBS disease was 1.13/1000 live births. One or more antepartum or intrapartum predisposing factors were recognized in 62% of cases. Early-onset was noted in 65 (80%) neonates (23 asymptomatic and 42 symptomatic). All full-term infants survived. The mortality was 6% and was confined to preterm neonates with early symptomatic disease who presented with shock and had thrombocytopenia.

Conclusion: Antepartum or intrapartum known predisposing risk factors of GBS disease were lacking in one third of patients. Patients who died were preterm infants in the early symptomatic group.

Publication types

  • Multicenter Study

MeSH terms

  • Adult
  • Bacteremia* / microbiology
  • Bacteremia* / mortality
  • Female
  • Humans
  • Incidence
  • Infant, Newborn
  • Infant, Newborn, Diseases* / microbiology
  • Infant, Newborn, Diseases* / mortality
  • Infant, Premature
  • Meningitis* / microbiology
  • Meningitis* / mortality
  • Ontario / epidemiology
  • Pregnancy
  • Retrospective Studies
  • Risk Factors
  • Shock
  • Streptococcal Infections / diagnosis
  • Streptococcal Infections / mortality*
  • Streptococcal Infections / physiopathology*
  • Streptococcus agalactiae / pathogenicity*
  • Thrombocytopenia